MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Laboratory Corp of America Holdings

Cerrado

Sector Salud

249.13 0.06

Resumen

Variación precio

24h

Actual

Mínimo

249.13

Máximo

250.62

Métricas clave

By Trading Economics

Ingresos

-36M

170M

Ventas

47M

3.3B

P/B

Media del Sector

28.002

73.394

BPA

3.45

Rentabilidad por dividendo

1.16

Margen de beneficio

5.168

Empleados

70,000

EBITDA

-206M

217M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+10.9 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.16%

3.09%

Próximas Ganancias

24 abr 2025

Fecha Próximo Dividendo

12 mar 2025

Próxima Fecha de Ex Dividendo

27 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

21B

Apertura anterior

249.07

Cierre anterior

249.13

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

67 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Laboratory Corp of America Holdings Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

22 feb 2025, 00:16 UTC

Acciones populares

Stocks to Watch: Alamos Gold, Booking Holdings

22 feb 2025, 16:33 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 15:15 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 14:32 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 13:49 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 13:22 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

21 feb 2025, 23:22 UTC

Principales Noticias

DOGE Aide's IRS Access Won't Include Personal Information -- Update

21 feb 2025, 23:20 UTC

Ganancias

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

21 feb 2025, 22:34 UTC

Charlas de Mercado

L'Oréal Cuts Exposure to Chinese Market, Grows Emerging Markets -- Market Talk

21 feb 2025, 22:12 UTC

Principales Noticias

DOJ Investigates Medicare Billing Practices at UnitedHealth -- 2nd Update

21 feb 2025, 21:54 UTC

Principales Noticias

Why Is Warren Buffett Hoarding So Much Cash? -- 2nd Update

21 feb 2025, 21:51 UTC

Ganancias

Tesla Stock Falls. Recalls and Rivian Are in the News. -- Barrons.com

21 feb 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

21 feb 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

21 feb 2025, 21:50 UTC

Principales Noticias

DOGE Aide's IRS Access Won't Include Personal Information -- WSJ

21 feb 2025, 21:48 UTC

Charlas de Mercado
Ganancias

L'Oréal Tops Estée Lauder in Luxury U.S. Market, CEO Says -- Market Talk

21 feb 2025, 21:35 UTC

Charlas de Mercado

Bulk of U.S. Imports From Canada Used to Make U.S. Goods -- Market Talk

21 feb 2025, 21:28 UTC

Principales Noticias

Why Is Warren Buffett Hoarding So Much Cash? -- Update

21 feb 2025, 21:24 UTC

Principales Noticias

Major U.S. Stock Indexes Give Up Gains From the Week -- WSJ

21 feb 2025, 21:19 UTC

Charlas de Mercado

Mexico's Inflation Seen Up in Early February -- Market Talk

21 feb 2025, 20:15 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

21 feb 2025, 20:15 UTC

Charlas de Mercado

JPMorgan Chase Branch Expansion Portends Deposit Growth -- Market Talk

21 feb 2025, 20:05 UTC

Charlas de Mercado

Oil Futures Retreat Into the Weekend Again -- Market Talk

21 feb 2025, 19:58 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Third Straight Weekly Gain -- Market Talk

21 feb 2025, 19:29 UTC

Charlas de Mercado

Gold Slides After Finding Record High -- Market Talk

21 feb 2025, 19:26 UTC

Principales Noticias

Major U.S. Stock Indexes Slip; UnitedHealth Pulls Down DJIA -- WSJ

21 feb 2025, 19:05 UTC

Charlas de Mercado

Business Conditions Seen as Favoring Corporate Credit -- Market Talk

21 feb 2025, 19:02 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

21 feb 2025, 19:02 UTC

Charlas de Mercado

Corporate Credit Expected to Be Hit Unevenly by Trade Wars -- Market Talk

21 feb 2025, 19:00 UTC

Charlas de Mercado

Long-Term Treasury Yields Expected to Rise -- Market Talk

Comparación entre iguales

Cambio de precio

Laboratory Corp of America Holdings Esperado

Precio Objetivo

By TipRanks

10.9% repunte

Estimación a 12 meses

Media 277.08 USD  10.9%

Máximo 293 USD

Mínimo 248 USD

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Laboratory Corp of America Holdings Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

13 ratings

10

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

196.14 / 197.94Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

67 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.